NPI: 1881726347 · FLEMINGSBURG, KY 41041 · Certified Registered Nurse Anesthetist · NPI assigned 03/11/2007
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| Parent Organization | LIFEPOINT HEALTH INC |
| NPI Enumeration Date | 03/11/2007 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43,871 | $2.04M |
| 2019 | 44,467 | $2.10M |
| 2020 | 44,509 | $3.53M |
| 2021 | 47,085 | $3.54M |
| 2022 | 44,841 | $2.48M |
| 2023 | 40,215 | $2.62M |
| 2024 | 30,614 | $2.32M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,329 | 9,220 | $3.72M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,202 | 9,378 | $2.21M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,632 | 2,975 | $1.83M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,697 | 1,336 | $1.72M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 15,558 | 3,112 | $1.38M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 772 | 592 | $740K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,930 | 1,409 | $666K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5,738 | 1,729 | $496K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,526 | 3,396 | $457K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5,883 | 1,951 | $372K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,599 | 3,317 | $336K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,377 | 1,661 | $329K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,778 | 2,454 | $312K |
| 80053 | Comprehensive metabolic panel | 26,194 | 13,588 | $292K |
| 71046 | Radiologic examination, chest; 2 views | 4,455 | 3,420 | $263K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,107 | 3,096 | $237K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,620 | 1,539 | $220K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,281 | 2,720 | $173K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,102 | 3,069 | $169K |
| 71045 | Radiologic examination, chest; single view | 3,174 | 2,201 | $165K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,491 | 4,561 | $150K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,873 | 3,337 | $149K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,430 | 13,205 | $127K |
| G0378 | Hospital observation service, per hour | 196 | 109 | $104K |
| 36415 | Collection of venous blood by venipuncture | 15,610 | 6,927 | $97K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,865 | 2,216 | $95K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,258 | 2,462 | $90K |
| 84484 | 3,821 | 2,816 | $74K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,689 | 540 | $74K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 955 | 621 | $69K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 4,269 | 697 | $68K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,855 | 470 | $64K |
| 80061 | Lipid panel | 3,888 | 3,228 | $62K |
| 73630 | 881 | 737 | $60K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 313 | 261 | $60K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,911 | 3,487 | $56K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,790 | 3,555 | $54K |
| 87070 | 4,228 | 3,430 | $52K | |
| 73564 | 346 | 278 | $51K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,736 | 3,298 | $50K |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,389 | 2,846 | $50K |
| 83605 | 3,622 | 2,788 | $43K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,861 | 2,819 | $43K |
| 85730 | 2,692 | 2,151 | $37K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,247 | 3,365 | $37K |
| 81001 | 7,530 | 6,028 | $35K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 612 | 490 | $34K |
| 83880 | 1,085 | 822 | $33K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,100 | 1,808 | $32K |
| 73610 | 426 | 344 | $32K | |
| 97161 | 536 | 482 | $32K | |
| 83735 | 4,462 | 3,311 | $25K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 347 | 308 | $25K |
| 83690 | 3,934 | 3,153 | $24K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,064 | 932 | $24K |
| 72125 | Computed tomography, cervical spine; without contrast material | 31 | 25 | $24K |
| 81025 | 2,290 | 1,908 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,707 | 2,455 | $21K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 72 | 53 | $20K |
| 87040 | 1,091 | 777 | $20K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,121 | 947 | $19K |
| 85610 | 4,933 | 3,101 | $19K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,392 | 810 | $17K |
| 82607 | 1,342 | 1,010 | $13K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,316 | 633 | $13K |
| 84439 | 1,642 | 1,443 | $13K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 15 | 12 | $13K |
| 87077 | 1,700 | 919 | $13K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 13 | 12 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 589 | 502 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 632 | 530 | $11K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 51 | 40 | $9K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 42 | 40 | $9K |
| 73030 | 114 | 95 | $8K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 33 | 26 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 175 | 140 | $7K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 22 | 12 | $7K |
| 85379 | 673 | 551 | $7K | |
| 87807 | 501 | 460 | $7K | |
| 97162 | 79 | 69 | $7K | |
| 76536 | 46 | 39 | $7K | |
| J2704 | Injection, propofol, 10 mg | 695 | 484 | $6K |
| 72100 | 43 | 24 | $6K | |
| 73130 | 118 | 95 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 80 | 61 | $6K |
| 82962 | 1,121 | 571 | $6K | |
| 82746 | 407 | 367 | $5K | |
| 87186 | 616 | 469 | $5K | |
| 76642 | 62 | 53 | $5K | |
| 86140 | 663 | 486 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 64 | 52 | $4K |
| 82728 | 370 | 317 | $4K | |
| 83540 | 621 | 539 | $3K | |
| 73110 | 45 | 40 | $3K | |
| 83550 | 453 | 409 | $3K | |
| 83921 | 102 | 98 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 504 | 348 | $2K |
| 96376 | 82 | 38 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 21 | 15 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,859 | 1,437 | $2K |
| 84703 | 193 | 181 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 622 | 484 | $1K |
| 90715 | 40 | 37 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,429 | 1,905 | $1K |
| 12001 | 15 | 13 | $1K | |
| 96367 | 35 | 21 | $1K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 44 | 37 | $694.05 |
| 82803 | 39 | 24 | $663.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,213 | 1,014 | $651.27 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 50 | 36 | $558.44 |
| 94760 | 47 | 41 | $487.43 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 592 | 415 | $453.55 |
| 82150 | 62 | 54 | $437.18 | |
| 85045 | 61 | 56 | $396.57 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 458 | 329 | $374.45 |
| 82565 | 15 | 13 | $213.61 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 229 | 205 | $195.99 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 423 | 376 | $178.77 |
| 85652 | 31 | 25 | $154.41 | |
| 87205 | 29 | 25 | $140.15 | |
| J7050 | Infusion, normal saline solution, 250 cc | 103 | 33 | $125.70 |
| 81003 | 24 | 14 | $60.40 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 14 | 13 | $6.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 20 | 15 | $0.00 |